11. Income Taxes

 

  

Year Ended January 31,

 
  

2026

  

2025

 
  

(in thousands)

 

Income (loss) before income taxes is attributable to the following jurisdictions:

        

Domestic

 $(8,333) $(6,049)

Foreign

  11,234   13,107 

Total

 $2,901  $7,058 

The components of income tax expense (benefit) were as follows:

        

Current:

        

Domestic

 $  $2 

Foreign

  2,366   1,947 
   2,366   1,949 

Deferred:

        

Domestic

      

Foreign

  (215)  35 
   (215)  35 

Income tax expense

 $2,151  $1,984 

 

The following is a reconciliation of expected to actual income tax expense:

 

  

Amount

  

Percentage

 

Federal income tax at 21%

 $609   21%

Nontaxable or nondeductible Items

        

Global intangible low tax income ("GILTI") inclusion

  2,040   70.32%

Excess tax deficiency for share-based payments under ASU 2016-09

  624   21.51%

Other reconciling items

  (12)  (0.41%)

Changes in Valuation Allowance

  (903)  (31.13%)

Foreign Tax Effects

        

Canada

        

Nondeductible Fines and Penalties

  98   3.38%

Other

  (34)  (1.17%)

United Kingdom

        

Changes in Valuation Allowance

  196   6.76%

Deferred tax rate change

  (180)   

Other

  23   0.79%

Singapore

        

Statutory tax rate difference between Singapore and U.S.

  (428)  (14.75%)

Depreciation & Amortization

  117   4.03%

Statutory Adjustments

  441   15.20%

Other

  (23)  (0.79%)

Malaysia

        

Changes in Valuation Allowance

  (295)  (10.17%)

Statutory Adjustments

  (164)  (5.65%)

Other

  42   1.45%
  $2,151   74.15%

 

  

Year Ended

 
  

January 31,

 
  

2025

 
     

Federal income tax at 21%

 $1,482 

Taxes created by return to provision adjustments to prior year temporary differences

  110 

Global intangible low tax income ("GILTI") inclusion

  2,449 

Permanent differences

  61 

Foreign effective tax rate differential

  (429)

Valuation allowance on deferred tax assets

  (1,903)

Excess tax deficiency for share-based payments under ASU 2016-09

  149 

Other

  65 
  $1,984 

 

The components of the Company’s deferred taxes consisted of the following:

 

  

As of January 31,

 
  

2026

  

2025

 
  

(in thousands)

 

Deferred tax assets:

        

Net operating losses

 $24,820  $24,613 

Tax credit carry forwards

  334   334 

Stock option book expense

  278   581 

Allowance for credit losses

  97   98 

Inventory

  438   475 

Accruals not yet deductible for tax purposes

  132   113 

Fixed assets

  12   63 

Intangible assets

  1   948 

Disallowed interest expense

  100   98 

Other

  1,243   945 

Gross deferred tax assets

  27,455   28,268 

Valuation allowance

  (27,153)  (28,181)

Deferred tax assets

  302   87 

Deferred tax liabilities:

        

Other

      

Deferred tax liabilities

      

Unrecognized tax benefits

      

Total deferred tax liabilities, net

 $  $ 

 

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. This legislation introduces several measures, including the permanent extension of select provisions from the Tax Cuts and Jobs Act, revisions to the international tax framework, and the reinstatement of favorable tax treatment for certain business-related items. The OBBBA contains multiple effective dates, with key provisions beginning in fiscal 2026. While we are still assessing the overall impact of the OBBBA, we do not anticipate a material impact on our tax expense.

 

The Company has determined that, due to the potential requirement for additional investment and working capital to achieve its objectives, the undistributed earnings of foreign subsidiaries as of January 31, 2026, are not deemed indefinitely reinvested outside of the United States. However, determination of the amount of deferred taxes with respect to the undistributed foreign earnings is not practicable. Therefore, the Company has not recorded a deferred tax liability associated with the undistributed foreign earnings as of January 31, 2026.

 

Included in deferred tax assets is approximately $278,000 related to stock-based compensation, including non-qualified stock options. Recent market prices for the Company’s Common Stock remain below the exercise price of a number of options outstanding as of January 31, 2026. Should the market price of the Company’s Common Stock remain below the exercise price of the options, these stock options will expire without exercise. In accordance with the provisions of ASC 718-740-10, a valuation allowance has not been computed based on the decline in stock price.

 

As of January 31, 2026, the Company has recorded valuation allowances of approximately $27.2 million related to deferred tax assets. These deferred tax assets relate primarily to net operating loss carryforwards in the United States and other jurisdictions. These net operating loss carry forwards are subject to limitation and future expiration. The valuation allowances were determined based on management’s judgment as to the likelihood that the deferred tax assets would not be realized. The judgment was based on an evaluation of available evidence, both positive and negative.

 

On  January 31, 2026, the Company had tax credit carry forwards of approximately $334,000, which amounts can be carried forward through at least 2027.

 

As of January 31, 2026, and 2025 the Company had no unrecognized tax benefits attributable to uncertain tax positions.

 

The Company recognizes interest and penalties related to income tax matters as a component of income tax expense.

 

The Company files U.S. federal income tax returns as well as separate returns for its foreign subsidiaries within their local jurisdictions. The Company’s U.S. federal tax returns are subject to examination by the IRS for fiscal years ended January 31, 2022, through 2026. The Company’s tax returns may also be subject to examination by state and local revenue authorities for fiscal years ended January 31, 2021, through 2026. The Company’s Singapore income tax returns are subject to examination by the Singapore tax authorities for fiscal years ended January 31, 2018, through 2026. The Company’s tax returns in other foreign jurisdictions are generally subject to examination for the fiscal years ended January 31, 2019 through January 31, 2026.

 

Historical Timeline

Fiscal YearFiled
2026Apr 20, 2026Showing above
2025Apr 25, 2025
2024Apr 30, 2024
2023May 1, 2023
2022Apr 29, 2022
2021Apr 16, 2021
2020Apr 28, 2020
2019Apr 5, 2019
2018Apr 13, 2018
2017Apr 7, 2017
2016Apr 7, 2016

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.